The Claim
High-intensity statin therapy causes a 36% relative increase in new-onset diabetes diagnoses compared to placebo, with an absolute annual risk increase of 1.27%, driven by a small mean HbA1c rise of 0.08%, and primarily affecting individuals whose baseline glycaemic levels are already in the top 25% of the population distribution.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking strong statin drugs might slightly raise your chance of getting type 2 diabetes, especially if your blood sugar was already on the higher side to begin with.
See the scientific wording
High-intensity statin therapy causes a 36% relative increase in new-onset diabetes diagnoses compared to placebo, with an absolute annual risk increase of 1.27%, driven by a small mean HbA1c rise of 0.08% and primarily affecting individuals whose baseline glycaemic levels are already in the top 25% of the population distribution.
What the research says
1 studyThe study found that strong statin treatment slightly raises the chance of getting diabetes, especially in people who already have high blood sugar, which matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.